Company Filing History:
Years Active: 2007-2008
Title: Christine Schuell: Innovator in Cancer Treatment
Introduction
Christine Schuell is a prominent inventor based in Penzberg, Germany. She has made significant contributions to the field of medicine, particularly in cancer treatment. With a total of 2 patents, her work focuses on innovative therapeutic agents aimed at inhibiting tumor growth.
Latest Patents
Christine's latest patents include groundbreaking research on thiazolidinediones. These compounds are used alone or in combination with other therapeutic agents to inhibit or reduce tumor growth. Additionally, she has developed methods for using thiazolidinedione derivatives in the preparation of medicaments for treating cancer. Another notable patent involves phthalazinone derivatives, which are disclosed along with their pharmaceutically acceptable salts and methods for preparation. These compounds are aimed at treating, controlling, or preventing illnesses such as cancer.
Career Highlights
Christine Schuell is currently associated with Hoffmann-La Roche Inc., where she continues to advance her research in oncology. Her work has been instrumental in developing new treatment options for patients suffering from cancer.
Collaborations
Some of her notable coworkers include Edward Andrew Boyd and Frederick Arthur Brookfield. Their collaborative efforts have contributed to the success of her innovative projects.
Conclusion
Christine Schuell's contributions to cancer treatment through her patents and research are invaluable. Her dedication to innovation in medicine continues to inspire advancements in therapeutic agents.